Manufacture of hydrated nanocellulose sheets for use as a dermatological treatment
09970159 ยท 2018-05-15
Assignee
Inventors
Cpc classification
D21C9/18
TEXTILES; PAPER
D21H23/08
TEXTILES; PAPER
International classification
D21H23/08
TEXTILES; PAPER
D04H1/4382
TEXTILES; PAPER
Abstract
A hydrated, nonwoven nanocellulose sheet and method for manufacturing the nanocellulose sheet are disclosed. The method of manufacture comprises the steps of diluting a purified nanocellulose slurry to form a colloidal nanocellulose suspension, dispersing pure nanocellulose crystals into the nanocellulose suspension in a nanocellulose crystal to total nanocellulose ratio less than 50% weight per weight (w/w), placing the suspension over a filter sheet in a dispensing device, and forming the hydrated, nonwoven nanocellulose sheet by filtering with a pressure difference across the filter sheet, via a high pressure or vacuum filtration process. The hydrated, nonwoven nanocellulose sheet thus manufactured has high conformability, drape-ability, good adhesion to the skin, and a high rate of evaporation, making it ideal for dermatological treatments.
Claims
1. A method of manufacture for forming a hydrated, nonwoven nanocellulose sheet, the method comprising the steps of: providing a nanocellulose slurry; forming a first colloidal nanocellulose suspension by diluting the nanocellulose slurry with a suspension medium; dispersing nanocellulose crystals (CNC) into the first nanocellulose suspension in a CNC to total nanocellulose ratio below 50%, weight per weight (w/w), to form a second nanocellulose suspension; placing the second nanocellulose suspension over a filter sheet in a dispensing device; and forming the hydrated, nonwoven nanocellulose sheet by filtering the second nanocellulose suspension with a pressure difference across the filter sheet.
2. The method of claim 1, wherein the nanocellulose slurry comprises at least one of nanocellulose fibers (CNF) or CNC.
3. The method of claim 1, wherein the suspension medium comprises water, and the method further comprises: drying the nanocellulose sheet to a water content between 300% to 700% of nanocellulose weight, wherein the CNC to total nanocellulose ratio is between 0.001% to 10%.
4. The method of claim 1, further comprising: adding a CNC suspension in crystal weight percent composition between 0.001% and 10% to a surface of the hydrated, nonwoven nanocellulose sheet.
5. The method of claim 4, wherein the adding of the CNC suspension to the surface of the nanocellulose sheet is selected from the group consisting of dipping in, spraying with, and soaking in the CNC suspension.
6. The method of claim 1, wherein the second nanocellulose suspension has a nanocellulose concentration between 0.010% to 1% by weight.
7. The method of claim 1, wherein the suspension medium is oil-based.
8. The method of claim 7, further comprising: adding a polyelectrolyte to the first or second nanocellulose suspension in a polyelectrolyte to total nanocellulose ratio between 0.01% to 84% weight per weight (w/w) as a flocculation agent.
9. The method of claim 1, wherein the nanocellulose slurry comprises both nanocellulose fibers (CNF) and CNC.
10. The method of claim 1, wherein the nanocellulose slurry has a solid content between 1% and 12% by weight.
11. The method of claim 1, wherein the first nanocellulose suspension has a mass concentration between 0.01 gram per liter to 10 grams per liter, after the diluting with the suspension medium.
12. The method of claim 1, wherein the CNC to total nanocellulose ratio in the second nanocellulose suspension is between 1% and 20% w/w.
13. The method of claim 1, wherein the CNC to total nanocellulose ratio in the second nanocellulose suspension is between 0.1% and 10% w/w.
14. The method of claim 1, wherein the nanocellulose sheet has a solid content between 10-50% by weight.
15. The method of claim 1, further comprising: adding a binding agent to the first or second nanocellulose suspension, wherein a mass concentration of the binding agent in the nanocellulose suspension is between 0.001 grams per liter to 10 grams per liter.
16. The method of claim 1, further comprising: adding a binding agent to a surface of the nanocellulose sheet in a binding agent to total nanocellulose ratio between 0.001% to 10% weight per weight (w/w).
17. The method of claim 1, further comprising: adding a hydrophilic pore former to the first or second nanocellulose suspension, wherein a pore former to total nanocellulose ratio is between 5% and 75% weight per weight (w/w).
18. The method of claim 1, further comprising: adding a hydrophilic pore former to a surface of the nanocellulose sheet, wherein a pore former to total nanocellulose ratio is between 5% and 75% weight per weight (w/w).
19. The method of claim 1, wherein the pressure difference is achieved using a positive pressure or vacuum across the filter sheet.
20. The method of claim 1, further comprising: adding an amount of an additive ingredient to the first or second nanocellulose suspension, wherein the additive ingredient is selected from the group consisting of silver, collagen, proteins, fragrances, antioxidants, cellulose fibers, cellulose nanocrystals, nanoclay, extended release particles, micro-encapsulates, polyelectrolyte, and polyether.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1) Embodiments of the present invention described herein are exemplary, and not restrictive. Embodiments will now be described, by way of examples, with reference to the accompanying drawings. For purposes of clarity, not every component is labeled in every drawing. The drawings are not drawn to scale, with emphasis instead being placed on illustrating various aspects of the techniques and devices described herein.
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
DETAILED DESCRIPTION OF THE INVENTION
(17) In the following description, for purposes of explanation, numerous specific details are set forth in order to provide a thorough understanding of the invention. It will be apparent, however, to one skilled in the art that the invention can be practiced without these specific details. In other instances, structures, devices, activities, methods, and processes are shown using schematics, use cases, and/or diagrams in order to avoid obscuring the invention. Although the following description contains many specifics for the purposes of illustration, anyone skilled in the art will appreciate that many variations and/or alterations to suggested details are within the scope of the present invention. Similarly, although many of the features of the present invention are described in terms of each other, or in conjunction with each other, one skilled in the art will appreciate that many of these features can be provided independently of other features. Accordingly, this description of the invention is set forth without any loss of generality to, and without imposing limitations upon, the invention.
(18) Overview
(19) Broadly, embodiments of the present invention relate to a hydrated, nonwoven nanocellulose sheet, and methods and systems for manufacturing the nanocellulose sheet. The hydrated, nanocellulose sheet is formed through a pressured filtration process from a diluted nanocellulose suspension. Various additives may be dissolved or dispensed into the diluted nanocellulose suspension in controlled steps or sequences. Such additives include, but are not limited to, binding agents, cross-linking agents, dermatologically active ingredients, morphology-altering particles, base material modifiers, pure nanocellulose crystals, polyelectrolytes, and pH modifying solutions. Binding agents added to the nanocellulose suspension improve the strength of the nonwoven nanocellulose sheet. Such binding agents may alternatively be activated or cross-linked after the formation of the sheet by applying other chemical agents or treating the sheet after formation. Similarly, additive ingredients as listed above may be applied to the sheet after formation of the nanocellulose sheet, via mechanisms such as spraying, dipping, soaking, and the like.
(20) The elements and process of manufacturing the hydrated, nonwoven nanocellulose sheet produce several advantageous properties, include high conformability, drape-ability, large surface area, good levels of adhesion to the skin of a user, ability to contain and effectively deliver nano and micro particles, high porosity, and high rate of evaporation of water from the sheet. These properties make the nanocellulose sheet ideal for resting against the skin of a user and delivering dermatological agents which are generally difficult to do or which require multi-step processes to be delivered to the skin.
(21) Furthermore, some embodiments of the present invention introduce pure nanocellulose crystals into the nanocellulose sheet production process, which increases the overall strength of the sheet produced, making it less likely to tear, while reducing the sheet drying time. Conventionally, high levels of hydration are desirable and crystals are not used in nanocellulose sheet production because they do not swell in the presence of an aqueous solution. Embodiments of the present invention carefully balances the use of nanocellulose crystals and nanocellulose fibers to achieve desired hydration levels while enhancing sheet durability and tensile strength, and reducing overall processing times.
(22) Moreover, a novel polyelectrolyte addition process during nanocellulose sheet production is disclosed herein to allow the porosity and extrinsic charge sites within the formed sheets to be tuned by varying a ratio of the polyelectrolyte to the nanocellulose. Polyelectrolytes have been frequently used to form multilayers and free standing thin films. Unlike traditional polyelectrolyte complexes where a solid precipitate is formed, such as between Polystyrene Sulfonate (PSS) and poly(diallyldimethylammonium chloride) (PDADMAC), in embodiments of the present invention, polyelectrolytes act as a scaffold and ion exchange sites, bind to the nanocellulose upon filtration without forming any solid precipitates.
(23) Dermatological Applications of Nanocellulose Sheets
(24)
(25) In some embodiments, sheet 110 may be cut into different forms, including different shapes, sizes or configurations that facilitate direct application to the skin. The different shapes and sizes may be used for different skin-contact applications on different parts of a user's body. Exemplary applications include, but are not limited to, wound healing, dermatology, and cosmetology.
(26)
(27)
(28) As disclosed herein, hydrated, nonwoven nanocellulose sheets produced according to embodiments of the present invention may incorporate dermatologically active ingredients to enhance the effects of applying a hydrated sheet mask. To produce a nanocellulose sheet such as 110, a series of steps may be carried out.
(29) Nanocellulose Sheet Production
(30)
(31) At step 316, the nanocellulose is diluted into a suspension medium to form a nanocellulose suspension. In some embodiments, the nanocellulose is diluted to a mass concentration between 0.01 gram per liter to 10 grams per liter. In some embodiments, the nanocellulose is diluted to a mass concentration between 0.1 gram per liter to 10 grams per liter. In some embodiments, the nanocellulose is diluted with a suspension medium capable of being combined with the cellulose to form a stable suspension. Exemplary suspension media include, but are not limited to, water, alcohols, or oil. In some embodiments, an oil-based suspension medium may further comprise a surfactant.
(32) The dilution of nanocellulose into a suspension and subsequent usage of such a nanocellulose suspension in sheet production is beneficial as they allow nanocellulose material to be accepted from multiple sources. For example, grown pellicles of nanocellulose are commonly obtained in bacterially grown cellulose. In some embodiments, the nanocellulose material may be pre-treated before nanocellulose formation from cellulose fibers. Such pre-treatments may include mechanical or enzymatic treatment of a cellulose containing material. For example, cellulose containing material may be oxidized using 2,2,6,6-tetramethylpiperidin-1-oxyl radical (TEMPO), which introduces charged groups. Carboxymethylation may also be used to pre-treat the cellulose containing material. Finally, acid hydrolysis may be used to treat the cellulose containing material.
(33) Next, at step 327, the nanocellulose suspension is placed into a dispensing device for a filtering or micro-filtration process, where the suspension is filtered at step 328 to form a nanocellulose sheet. The dispensing device may be a device capable of micro-filtration and/or fabricating sheets of nanomaterials, using positive pressure or vacuum across a filter medium such as a filter paper or filter membrane, to produce large, uniform-thickness sheets of nanomaterials of variable sizes, shapes, and thicknesses. An exemplary device that may be used in embodiments of the present invention and is discussed in more detail with reference to
(34) Other optional steps shown in
(35) In some embodiments, each of the binding and cross-linking solution may be prepared by diluting a binding agent or a cross-linking agent to suitable mass concentrations. For example, between 0.001 grams per liter to 100 grams per liter, 0.001 grams per liter to 10 grams per liter, 0.01 grams per liter to 10 grams per liter, or 0.01 grams per liter to 20 grams per liter. The nanocellulose sheet may be dipped into the binding solution only, the cross-linking solution only, or one solution after the other. Exemplary wet binding agent or gelling agents include sodium alginate, agar, any polycationic, such as polyamidoamine-epichlorohydrin or KYMENE, and any anionic such as carboxymethylcellulose or Hyaluronic acid. Sodium alginate is a negatively charged polymer that forms a hydrogel. Addition of sodium alginate helps retain water well against outside forces. Exemplary cross-linking agents include calcium lactate, calcium chloride, calcium stearate or oil, which may be capable of cross-linking or setting the binding agent, where relevant. Moreover, although a dipping action is referred to in steps 330 and 322, in some embodiments, similar operations such as spraying, soaking, and the like may be performed instead.
(36) In this embodiment and other embodiments disclosed herein, the term ingredient or additive ingredient collectively refers to one or more of the following materials: particulate or solution-based dermatologically active ingredients, base material modifiers including pure nanocellulose crystals, morphology-altering particles, and other similar additives. One or more additive ingredients may be added to the nanocellulose suspension before the micro-filtration process, or may be added to the formed sheet after the micro-filtration process such as shown by step 332 in
(37) Many known particulate or solution-based materials may be used as additive ingredients. Exemplary dermatologically active ingredients include, but are not limited to, silver, collagen, proteins, fragrances or antioxidants such as blended green tea. Exemplary base material modifiers include, but are not limited to, other forms of cellulose fibers, other forms of nanofibers such as cellulose nanocrystals (CNC), nanoclay, extended release particles, micro-encapsulates, polyelectrolytes such as poly(diallyldimethylammonium chloride) (PDADMAC), and polyether such as Polyethylene glycol (PEG).
(38) In general, when only nanocellulose fiber or 100% cellulose nanofibers (CNF) are diluted into a nanocellulose suspension, without additive ingredients, a hydrogen-bonded network of polymer chains is formed during sheet formation, capable of holding several times its mass in water. When this network interacts with external additives, the external additives inhibit the hydrogen bonding capabilities of the 100% CNF network, which causes a decrease in an extent of hydration (EOH). A decrease in EOH may be beneficial for a variety of applications that require shorter processing times and lower EOH values, such as cosmetic applications that need specific amounts of water with good durability.
(39) As mentioned above, one additive ingredient may be CNC, which are crystalline regions of CNF. When added, CNC neither swell significantly, nor exhibits of the available H-bonding sites, thus causing the manufactured nanocellulose sheet to hold less water.
(40) Another additive ingredient may be a polyelectrolyte such as PDADMAC, which is a positively charged polymer that directly binds with negatively charged CNF, and significantly reduces EOH. By varying the proportion of PDADMAC to CNF, an extent of intrinsic ionic compensation may be tuned, reflecting how many charged groups from each chain interact with one another.
(41) In
(42) Although not shown explicitly in
(43) A hydrated, nonwoven nanocellulose sheet manufactured according to embodiments of the present invention have high conformability and drape-ability, a high surface area, a good level of adhesion to the skin, the ability to trap nano and micro particles, high porosity, and a high rate of evaporation of water from the sheet. Conformability, drape-ability, high surface area and adhesion to the skin are characteristics that make the nanocellulose sheet ideal for lying against the skin. The ability to contain nano and micro particles, as well as absorbing aqueous solutions, make the material ideal as a delivery mechanism for dermatological agents that are known to be difficult to deliver, or require multi-step processes to deliver to the skin. Thus, a hydrated, nonwoven nanocellulose sheets such as 110, 200, 220, 240, or 260 are capable of delivering dermatological agents or other ingredients more effectively and for a longer period of time than conventional sheet masks.
(44)
(45) More specifically, similar to the process shown in
(46) An optional step 417 may then be performed to add an amount of ingredients to the nanocellulose suspension. Different types of ingredients are previously discussed with reference
(47) Next, at step 418, a binding agent is added to the nanocellulose suspension. At step 420, a cross-linking agent is diluted in a solvent, such as water, to form a cross-linking solution. At step 422, the nanocellulose suspension is dispensed into the cross-linking solution to form a gel.
(48) Similar to the embodiment illustrated by
(49) At step 424, the formed gel is collected from the mixture of the nanocellulose suspension and the cross-linking solution, and re-dispensed at step 426 into a solution to form a second nanocellulose suspension. The second nanocellulose suspension is then filtered at step 428 to form a nanocellulose sheet via positive or vacuum pressure.
(50) Optionally, the sheet is collected at step 430, dipped into an ingredient slurry of liquid or solid additive ingredients at step 432, and cut into a desirable form and packaged at step 434.
(51) In some embodiments, including when both steps 417 and 432 are performed in the process shown in
(52)
(53) The suspension medium may be any suspension medium capable of being combined with the nanocellulose to form a stable suspension. Exemplary suspension media include, but are not limited to, water, alcohols or oil, which may further comprise a surfactant. In some embodiments, when the suspension medium is oil based, a polyelectrolyte may be further added to the suspension in a polyelectrolyte to total nanocellulose ratio between 0.01% to 84% weight per weight (w/w) as a flocculation agent.
(54) Once a nanocellulose suspension is formed, one or more of a binding agent, a cross-linking agent, or one or more additive ingredients may be added to the nanocellulose suspension. As discussed previously, an additive ingredient may be a base modifier such as cellulose nanocrystals (CNC), polymers, polyelectrolytes, pore formers, or dermatologically active ingredients. These additives may be added, mixed, dispensed, dispersed, or dissolved into the nanocellulose suspension in any desired order and proportions, in different embodiments of the present invention. For example, dermatologically active ingredients may be added after a polyelectrolyte dissolution into the nanocellulose suspension.
(55) In the embodiment shown in
(56) At step 527, the nanocellulose suspension is placed over a filter sheet in a dispensing device, and a hydrated, nonwoven nanocellulose sheet is fully formed at step 528 by filtering the nanocellulose suspension with a pressure difference across the filter sheet. The nanocellulose manufacture process terminates at step 540. Similar to the processes shown in
(57)
(58) More specifically, polyelectrolytes are a base modifier material capable of tuning the porosity and extrinsic charge sites within the formed nanocellulose sheet, and helping avoid the use of cross-linking chemicals during sheet production. In this embodiment, at step 617, a pH value of an aqueous nanocellulose suspension may first be adjusted by the addition of acids or bases, to deprotonate hydroxyl groups and induce negative surface charges to create electrostatic binding sites, before polyelectrolytes are added to the pH-adjusted suspension at step 618, wherein an ionic charge of the polyelectrolytes is an integer multiple of a nanocellulose backbone charge of the suspension. For instance, pH may be adjusted up using 1.0 M NaOH and down using 1.0 M HCl. Total deprotonation occurs at a pH level of 12.5, while partial deprotonation occurs at a pH level of 8.5, and a target pH level may be set at 8.4. High pH values may result in the degradation of cellulose through the production of isosaccharinic acid, but only for long time scales, such as weeks or months. In addition, hydrolysis may be performed at a pH less than 3 to cleave glycosidic linkages between cellulosic units, which results in shorter CNF chains that are unlikely to bind to a polycation. Further stirring of the suspension after the dissolving of the polyelectrolyte may help form polyelectrolyte complex networks, wherein a viscosity of the suspension may be in controlled ranges, such as between 0.890 centipoise (cP) inclusive and 500,000 cP inclusive, between 0.890 cP inclusive and 1,000 cP inclusive, or between 1 cP inclusive and 500 cP inclusive.
(59) In some embodiments, polyelectrolytes may be further added to one or both surfaces of the formed nanocellulose sheet in a total polyelectrolyte to total nanocellulose ratio between 0.01% to 84% weight per weight (w/w).
(60)
(61) In particular, at step 717, a first binding agent is added into the nanocellulose suspension. At step 718, a cross-linking agent is added into the nanocellulose suspension. These two steps are interchangeable in order. Similar to the embodiment illustrated by
(62) While not shown explicitly in
(63)
(64)
(65)
(66)
(67) In
(68) In obtaining the graphs shown in
(69) More specifically, filtration of the base nanocellulose suspension is performed to generate the 100% CNF graph 1030 according to
(70) As discussed with reference to
(71) When this hydrogen-bonded network interacts with external additives, the hydrogen bonding capabilities is inhibited, causing a decrease in an extent of hydration (EOH). Such a decrease in EOH is beneficial as it reduces overall processing time, especially when lower EOH is desired for particular applications that required specific amounts of water content with good sheet durability.
(72) In
(73) In
ADDITIONAL EMBODIMENTS
(74) In what follows, three additional exemplary embodiments are described for nanocellulose sheet production. Although the following description contains many specifics for the purposes of illustration, and many of the features of the present invention are described in terms of each other, or in conjunction with each other, one skilled in the art will appreciate that many of these features can be provided independently of other features. Accordingly, this description of the invention is set forth without any loss of generality to, and without imposing limitations upon, the invention.
Embodiment I
(75) 1) Providing a purified nanocellulose fiber slurry where fiber dimensions exist within the nanometer range for at least one of width or length. 2) Dispersion of the nanocellulose slurry into a solution or suspension medium to form a colloidal suspension over a range of dilute concentrations by weight. The nanocellulose may be diluted with any suspension medium capable of being combined with the nanocellulose to form a stable suspension. Exemplary suspension media include water, alcohol, and oil with surfactant. 3) Dispersion of pure nanocellulose crystals (CNCs) having 50-200 nm length and 5-25 nm width into the nanocellulose slurry. 4) Optional addition of a wet binding agent such as alginate or agar in 0.001-10% w/w to increase water retention during sheet formation. 5) Optional addition of a hydrophilic pore former in 5-75% w/w to increase a solubility of the cellulose nanocrystals. 6) Addition of dermatologically active or morphology-altering particles or other additives to the nanocellulose fiber and crystal suspension. 7) Filtration of the nanocellulose fiber and crystal suspension with positive pressure or vacuum to the filter paper such that a nanocellulose sheet of uniform thickness and roughness is formed. 8) Collection of the formed, hydrated, nonwoven nanocellulose sheet. 9) Optional addition of liquid or solid active agents or ingredients by dipping the formed sheet into an ingredient slurry. 10) Cutting the formed nanocellulose sheet into a form such as a facial mask, neck wrap, and under-eye masks, among other structures. 11) Packaging of sheet in a gas impermeable package to prevent water evaporation.
Embodiment II
(76) 1) Providing a purified nanocellulose fiber slurry where fiber dimensions exist within the nanometer range for at least one of width or length. 2) Dispersion of the nanocellulose into solution or suspension medium to form a colloidal suspension over a wide range of concentrations by weight. The nanocellulose may be diluted with any suspension medium capable of being combined with the nanocellulose to form a stable suspension. Exemplary suspension media include water, alcohol, and oil with surfactant. 3) Polyelectrolyte addition: a. If the dispersion medium is oil-based, addition of polyelectrolyte to the oil-based emulsion containing nanocellulose, for use as flocculation agent. b. If the dispersion medium is water-based, adjustment of aqueous nanocellulose suspension pH to deprotonate hydroxyl groups and induce negative surface charge to create electrostatic binding sites, and dissolution of polyelectrolyte such as poly(diallyldimethylammonium chloride) (PDADMAC) or chitosan in the aqueous suspension, in an ionic charge ratio as a multiple of backbone charges of nanocellulose. For example, 1:1 or 1:6, nanocellulose to polyelectrolyte. 4) Combining with stirring the nanocellulose suspension with polyelectrolyte to form a polyelectrolyte complex network suspension of variable viscosities. 5) Addition of particulate dermatologically active ingredients or desired base material modifiers to the nanocellulose suspension. 6) Filtration of the polyelectrolyte complex suspension with positive or vacuum pressure until a sheet is formed. 7) Collection of formed, nonwoven nanocellulose sheet. 8) Optional addition of liquid or solid active agents or ingredients by dipping the formed sheet into ingredient slurry, or spraying the form sheet with one or more ingredient solutions. 9) Optional Packaging of sheet in, for example, a gas-impermeable package.
Embodiment III
(77) 1) Providing a purified nanocellulose fiber slurry where fiber dimensions exist within the nanometer range for at least one of width or length. 2) Dispersion of the nanocellulose slurry into a solution or suspension medium to form colloidal suspension over a range of dilute concentrations by weight. The nanocellulose may be diluted with any suspension medium capable of being combined with the nanocellulose to form a stable suspension. Exemplary suspension media include water, alcohol, and oil with surfactant. 3) Addition of a wet binding agent such as alginate or agar increase water retention during sheet formation. 4) Addition of a cross-linking solution such as calcium chloride to form a gel. 5) Optional addition of a hydrophilic pore former in weight percent composition from 5-75% w/w to increase pore size distribution within formed nanocellulose sheet to decrease water retention. 6) Addition of dermatologically active or morphology-altering particles or other additives to the nanocellulose suspension. 7) Filtration of the nanocellulose suspension with positive pressure or vacuum to the filter paper such that a nanocellulose sheet of uniform thickness and roughness is formed. 8) Collection of the formed, nonwoven nanocellulose sheet. 9) Optional addition of liquid or solid active agents or ingredients by dipping the formed sheet into ingredient slurry, or spraying the form sheet with one or more ingredient solutions. 10) Cutting the formed nanocellulose sheet into a form such as a facial mask, neck wrap, and under-eye masks, among other structures. 11) Packaging of sheet in a gas impermeable package to prevent water evaporation.
(78) One of ordinary skill in the art knows that the use cases, structures, schematics, and flow diagrams may be performed in other orders or combinations, but the inventive concept of the present invention remains without departing from the broader scope of the invention. Every embodiment may be unique, and methods/steps may be either shortened or lengthened, overlapped with the other activities, postponed, delayed, and continued after a time gap, such that every user is accommodated to practice the methods of the present invention.
(79) Although the present invention has been described with reference to specific exemplary embodiments, it will be evident that the various modification and changes can be made to these embodiments without departing from the broader scope of the invention. Accordingly, the specification and drawings are to be regarded in an illustrative sense rather than in a restrictive sense. It will also be apparent to the skilled artisan that the embodiments described above are specific examples of a single broader invention which may have greater scope than any of the singular descriptions taught. There may be many alterations made in the descriptions without departing from the scope of the present invention.